The cell series are prepared in the laboratory of Dr. John Tisdale, a senior researcher at the National Laboratory of National Heart, Pulmonary Pulmonary and Blood of the Institute and Molecular Therapeutics, at the National Institutes of Health in Bethesda in Maryland. (Photo by Brendan Smialowski / AFP (photo by Brendan Smialowski / AFP via Getty Images)
AFP via Getty Images
President Trump is committed Provide Americans a highly reformed health care system that is accessible, innovative and increases patient care above anywhere else in the world. Despite the games of political shells played by the Liberal Democrats, the media and even some Republicans, much of the agenda of President Trump’s policy has widespread public support and is largely on the right track to succeed, if established.
For example, recently poll McLaughlin & Associates shows more than 85% of potential voters favor his policy of bypassing the costly fees of intermediary, allowing immediate medication sales to patients. Throughout the Board of Directors, his policies – from the demand of foreign countries to pay their fair share of US medical innovations, to ensure unprecedented domestic drug construction investments in view of the emerging threats from China to secure Manager Manager Phar.
Who would believe that Donald Trump could make health care an “80/20” political issue for conservatives? The biggest question, however, is whether the Republicans of Congress, who have long been disadvantaged among voters on the subject, will embrace his agenda and help pass it.
Do not make any mistake, the opportunity is right in front of them. Most Americans would probably agree that no one would design a healthcare system that looks like what we have. It is confusing, full of bureaucracy, waste, fraud and abuse, manipulated by corporate intermediaries and is overly expensive for patients, employers and taxpayers to maintain. At the same time, however, the American system develops, manufactures and delivers the most innovative medical treatments in the world. He does not add that America can be at the forefront of innovation and investment, while drowning in outdated systems that bankrupt families and taxpayers from billions of dollars.
These are complex problems that have often led to overly complex and often self -serving politically guided policies that have made problems much worse for patients and families. President Joe Biden’s changes to Medicare – part of the Democratic (IRA) spending bill (IRA) is a perfect recent example. In addition to the billions of dollars in the so -called Medicare savings to finance irrelevant subsidies for large insurers, electric vehicles and other special interests, IRA drug control measures have led to huge high quality points, R&D in new Cures and Cutting-Enter-Engines.
To be fair, President Trump also threatened to use heavy -handed prices on prescription drugs. However, its overall policy proposals, which require greater accountability, competition and transparency in healthcare – along with the power of nature that brings to the negotiation process – will achieve even greater results until such prices are unnecessary. We must assume that he is aware of this, because during his first four years, the rise in drug prices remained in historical low.
Just eight months after his second term, President Trump has already exerted unprecedented pressure on foreign governments to pay their fair share of US drug innovations, worked to expose and accelerate costs in Labor potential.
In short, President Trump proves to be the final control of prices in health care. And he does it without really applying such unnecessary measures-and should not-so avoid the negative impacts of access and innovation that would have had impact on patients, families, innovative and workers.
In addition, there are many other policies aligned with Trump that are considered to help promote America. They include the requirement of other countries to set NATO -resemble investment limits to ensure that the US is not bringing world costs for medical innovation, accelerating FDA revisions for a lower cost and utilizing AI to accelerate innovation and innovation discoveries.
Overall, these “80/20” healthcare proposals and other free market reforms serve as its foundation “Most Favored Patient” program (I’m one of the managers) [mostfavoredpatient.org]An agenda that is aligned with Trump consisting of commonsense solutions and innovative policies to tackle daily health care problems and costs affecting almost every family. Now, thanks to President Trump, Republicans in Congress have a unique opportunity and platform to turn an issue that has historically been considered as a primary weakness in a victorious agenda addressed to all American patients, taxpayers and voters.
Here are some tips: don’t hesitate.
